Search Results for: cannabidiol

NIHC Receives USDA MAP Funding for International Research And Promotion Of Hemp

DISTRICT OF COLUMBIA: National Industrial Hemp Council today announced it received $200,000 in U.S. Department of Agricultural (USDA) Market Access Program (MAP) funding to support export market development of industrial hemp.

“We are grateful for USDA confidence and the recognition of NIHC as the industry leader in industrial hemp trade and marketing,” said Kevin Latner, NIHC’s Senior Vice President for Trade and Marketing who will be responsible for implementing the program.  “Today’s announcement makes NIHC a trusted partner to USDA for hemp fiber, feed, food and CBD companies looking to break down trade barriers in markets overseas.”

MAP funds are administered through USDA’s Foreign Agricultural Service (FAS). Through the MAP program, FAS partners with U.S. agricultural trade associations, cooperatives, state regional trade groups and small businesses to share the costs of overseas marketing and promotional activities that help build commercial export markets for U.S. agricultural products and commodities. These funds can be used for facilitating trade missions and meeting with industry stakeholders and government regulators overseas.

NIHC programs will focus on Europe and China and include market research, trade policy and trade facilitation.  The global industrial hemp and products market was estimated at $11.1 billion in retail sales in 2019.  With an annual growth rate of 52 percent, driven by continued strength in textiles, food and industrial uses and hemp-derived cannabidiol (CBD), the global market is forecast to be worth $89 billion by 2025.

Hemp for industrial use, textile and CBD market is expected to quickly expand and be the primary driver of global industry growth.  By 2021, the global trade of hemp is forecast $8.1 billion across all markets, representing a three-year compound annual growth rate (CAGR) of 83 percent.  EuropeChina, and Canada are currently the primary sources of industrial hemp.  With the passage of the 2018 Farm Bill, the U.S. has become the world’s third largest producer of industrial hemp.

Europe has rapidly developed a robust hemp and CBD market.  Europe is also a strong producer of industrial use hemp products with $424 million in industrial product sales. China has led global markets in textiles with almost 80 percent of the $1.7 billion hemp textile market, in 2019.

In addition, National Industrial Hemp Council members will now have unprecedented access to United States trade negotiators; foreign government counterparts; and a network of international hemp industry association counterparts. Foreign governments understand that NIHC is now supported by the U.S. government and represents U.S. industry interests.

Market Access Program funds can be used by NIHC throughout the world to support market access and trade policy work, international trade promotion including supporting business-to-business facilitation, and consumer and brand marketing.

MAP funds for 2021 will be administered to NIHC through the Food Export Association of the Midwest USA.    

“We’re extremely confident and trust that NIHC will represent the best interests of U.S. industrial hemp abroad. We’re excited to be working with them as part of the USDA cooperator community,” said Tim Hamilton, Executive Director of Food Export Association of the Midwest USA.

Governor Cuomo Announces Proposed Regulations For Cannabinoid Hemp Products

Department of Health’s Cannabinoid Hemp Program Will License Processors and Retailers and Set Quality Control Standards

NEW YORK:  Governor Andrew M. Cuomo today announced that the New York State Department of Health has filed proposed regulations to regulate cannabinoid hemp products in New York State. In accordance with legislation signed earlier this year by the Governor, the Department is creating a Cannabinoid Hemp Program. The Program will license both cannabinoid hemp processors and retailers and set quality control standards that all cannabinoid hemp products must meet.

“These regulations are the next step toward regulating the growing hemp industry in New York in a way that protects consumers and helps ensure the industry’s long-term viability,” said Governor Cuomo. “Establishing the State’s Cannabinoid Hemp Program to regulate production and sale of hemp and hemp extract will help protect both consumers and farmers.”

The Cannabinoid Hemp Program will organize and legitimize the cannabinoid market in New York State by creating a licensing framework for cannabinoid hemp processors and retailers, and by establishing basic manufacturing, packaging and labeling and laboratory testing standards. Currently, applications for cannabinoid hemp processing and retailing licenses are under development, and NYSDOH intends to make them available in early 2021.

In 2015, the Governor launched the Industrial Hemp Agricultural Research Pilot Program, supporting farmers and further boosting economic development in upstate New York. Since then, New York’s hemp program has expanded significantly, making New York one of the leading hemp producing states in the country, with more than 700 farmers and 100 manufacturers of hemp products. Hemp is a sustainable, carbon-sequestering crop that is capable of being transformed into hundreds of products including textiles, furniture, fuel, food, construction materials and personal care items.

Some hemp products that have been growing in popularity include cannabinoid hemp products such as Cannabidiol, or CBD, which can be found online or in retail stores throughout the state. While regulations exist at the federal level for the growth of hemp, there are currently no federal regulations for the processing and manufacturing of cannabinoid hemp products, resulting in the cannabinoid hemp marketplace lacking basic consumer protections that are common in similar industries. There are published reports of cannabinoid hemp products that do not contain any cannabinoids but contain unspecified or inconsistent levels of THC – the psychoactive component of the cannabis plant – or are contaminated with harmful toxins.

The proposed regulations fill this regulatory void and create a system allowing for the use of hemp-derived cannabinoids in certain foods, beverages, topicalsand dietary supplement products, provided regulatory requirements are satisfied. All cannabinoid hemp products must be manufactured using good manufacturing practices based on the end product’s intended use. The label must contain the total amount of cannabinoids in the product, number of cannabinoids per serving, a nutritional or supplement fact panel, information about whether the product contains THC and appropriate warnings stating the product is not intended for children, its use may cause the failure of a drug test, the product has not been evaluated by the FDA and if pregnant or nursing, to consult a healthcare provider before use.

Additionally, cannabinoid hemp products are required to be laboratory-tested before entering the market, with testing for their cannabinoid profile, heavy metals, microbial impurities, mycotoxins, pesticides and residual solvents. This information is required to be retrievable by the consumer in the form of a QR code or corresponding link on the product label. Retailers are prohibited from selling inhalable cannabinoid hemp products, such as vape products, to consumers under 21 years of age. Processors are prohibited from making claims suggesting the product will diagnose, cure, mitigate, treat or prevent disease.

New York State Department of Health Commissioner Dr. Howard Zucker said, “When you purchase a product, you should have confidence that what is stated on the label is actually in the product. With the increased production and use of cannabinoid hemp products, New York State could not wait for the federal government to act to institute basic consumer protections to protect the health and safety of New Yorkers.”

Senator Jen Metzger said, “These regulations will provide much-awaited certainty for the hemp industry and offer a tremendous opportunity for our farmers while ensuring that we have the standards consumers need for a safe and high-quality product. As the Senate sponsor of the bill that created the regulatory framework for hemp, I want to thank the Governor for his continued leadership to advance the hemp industry and move the regulatory process forward, and I urge New York farmers and all stakeholders to review the regulations and provide input during the 60-day comment period.”

Assembly Member Donna Lupardo said, “With these regulations, New York is creating a national model for consumer safety, requiring strict labeling and production standards. The inclusion of cannabinoid extracts in food and beverages will provide new economic opportunities for farmers, processors, manufacturers, and retailers throughout the state. I appreciate the Governor’s continued commitment to New York’s hemp industry and look forward to working with his administration as these regulations are finalized through the public comment period.”

For more information on New York’s Cannabinoid Hemp Program and to view the proposed regulations, please visit: https://health.ny.gov/regulations/hemp/.

Today Is World Alzheimer’s Day

September 21st is World Alzheimer’s Day, a date recognized by the Alzheimer’s Society globally. This important date marks the need to defend and raise awareness in society about the importance of prevention, early diagnosis and care offered, as well as support and assistance to family members and caregivers of people living with Alzheimer’s disease.

 

According to the WHO, it is estimated that there are around 50 million people with dementia in the world, and this number should triple in the next 30 years. Alzheimer’s disease is the most common form of dementia and can contribute to 60-70% of cases.

Dementia is one of the main causes of disability and dependence among elderly people around the world. Dementia has a physical, psychological, social and economic impact not only on people with dementia, but also on their caregivers, families and society in general.

 

Research on cannabis and Alzheimer’s continues to develop and may present an additional option for treatment

 

Different scientific studies highlight the use of medicinal cannabis for the treatment of Alzheimer’s symptoms. The main properties of cannabinoids for the treatment of symptoms would be: anti-inflammatory, neuroprotective and antioxidant.

 

Global medical affairs director of Spectrum Therapeutics, Dr. Wellington Briques, highlights some of these studies and their results below and is available for interviews.

 

 

Based on the complex pathology of Alzheimer’s disease, a preventive and multimodal drug approach that targets a combination of pathological symptoms of Alzheimer’s disease seems ideal. It is important to note that cannabinoids have anti-inflammatory, neuroprotective and antioxidant properties and have immunosuppressive effects

 

 

Studies have demonstrated the ability of the CBD to reduce reactive gliosis and neuroinflammatory response, as well as to promote neurogenesis. It is important to note that the CBD also reverses and prevents the development of cognitive deficits in AD rodent models. Interestingly, the combined therapies of CBD and Δ9-tetrahydrocannabinol (THC), show that CBD can antagonise the psychoactive effects associated with THC and possibly mediate greater therapeutic benefits than any of the phytochanabinoids alone. The studies provide “proof of principle” that CBD and possibly CBD-THC combinations are valid candidates for new AD therapies. Further research should address the long-term potential of CBD and evaluate the mechanisms involved in the therapeutic effects described.

 

The brain cells of Alzheimer’s patients often show a path of rapid decline and destruction. The potential to stimulate brain tissue has recently been discovered as a potential benefit of CBD. In clinical trials, the BDC has demonstrated the ability to reverse and even prevent the development of the negative impact of Alzheimer’s disease. A 2011 study by Australian researchers Tim Karl and Carl Group revealed that CBD promotes the growth and development of brain cells, reducing the decline in memory and other brain functions.

FDA Approves New Indication For Drug Containing An Active Ingredient Derived From Cannabis To Treat Seizures In Rare Genetic Disease

DISTRICT OF COLUMBIA: Last month, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older. Epidiolex was previously approved for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS). This is the only FDA-approved drug that contains a purified drug substance derived from cannabis. It is also the second FDA approval of a drug for the treatment of seizures associated with TSC.

CBD is a chemical component of the Cannabis sativa plant. However, CBD does not cause intoxication or euphoria (the “high”) that comes from tetrahydrocannabinol (THC). It is THC (and not CBD) that is the primary psychoactive component of cannabis.

“The FDA continues to believe the drug approval process represents the best way to make new medicines, including any drugs derived from cannabis, available to patients in need of appropriate medical therapy such as the treatment of seizures associated with these rare conditions. This paradigm ensures new therapies are safe, effective, and manufactured to a high quality that provides uniform and reliable dosing for patients,” said Douglas Throckmorton, M.D., deputy center director for regulatory programs in the FDA’s Center for Drug Evaluation and Research. “The agency is committed to supporting rigorous scientific research on the potential medical uses of cannabis-derived products and working with product developers who are interested in bringing patients safe and effective, high quality products.”

TSC is a rare genetic disease that causes non-cancerous (benign) tumors to grow in the brain and other parts of the body like the eyes, heart, kidneys, lungs, and skin. TSC usually affects the central nervous system and can result in a combination of symptoms including seizures, developmental delay, and behavioral problems, although the signs and symptoms of the condition, as well as the severity of symptoms, vary widely. TSC affects about 1 in 6,000 people.

Epidiolex’s effectiveness for the treatment of seizures associated with TSC was established in a randomized, double-blind, placebo-controlled trial where 148 patients out of a total of 224 in the study received Epidiolex. The study measured the change from baseline in seizure frequency. In the study, patients treated with Epidiolex had a significantly greater reduction in the frequency of seizures during the treatment period than patients who received placebo (inactive treatment). This effect was seen within eight weeks and remained consistent throughout the 16-week treatment period.

The most common side effects that occurred in Epidiolex-treated patients with TSC in the clinical trial were: diarrhea, elevated liver enzymes, decreased appetite, sleepiness, fever, and vomiting. Additional side effects for patients with LGS, DS, or TSC include: liver injury, decreased weight, anemia, and increased creatinine.

Epidiolex must be dispensed with a patient Medication Guide that describes important information about the drug’s uses and risks. As is true for all drugs that currently treat epilepsy, including Epidiolex, the most serious risks may include an increase in suicidal thoughts and behavior, or thoughts of self-harm. Patients, their caregivers, and their families should be advised to monitor for any unusual changes in mood or behavior, such as worsening depression, suicidal thoughts or behavior. Patients, caregivers, and families should report behaviors of concern immediately to healthcare providers. Epidiolex also caused liver injury in some patients. Most cases were generally mild, but a risk of rare, but more severe liver injury exists. More severe liver injury can cause nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, and/or dark urine.

The FDA granted Priority Review designation for this application. The approval of Epidiolex was granted to Greenwich Biosciences Inc., of Carlsbad, California.

Is Cannabis A Cure For Coronavirus?

MJNews Network Exclusive Report

By Lorelei Caudill

Are we potentially growing our own cure for this global pandemic?

Is the United States the most well-equipped country to potentially conduct one of the most extensive case studies in our world’s history?

Let’s take a more in-depth look at why the answer may be a yes.

In these times of uncertainty, globally, we are starting to look at science and data to help guide critical decisions to determine our new social norm needs. Cannabis is under the microscope on a global level since the beginning of this pandemic.

We are leaning on technology, data, and statistics on how and when to reopen our states and communities. We look to science to help us learn more about how the virus is spread. Some of the world’s best doctors have now taught us “How to wash our hands.” It seems a little crazy, right?

When we think of COVID19 and Cannabis, we need to do the same and lean scientific data from successful cannabis studies in the past (which is quite a bit, despite what many think) and watch the continuing studies with COVID19 scientists are conducting today on a global level.

Initially, some may say, “Nope, I consume cannabis, and I tested positive” (to be honest in my current COVID Survey has only been one person since I published on March 21st).

See the source image

Disregarding Cannabis as a potential to help with this global pandemic, is like saying you wash your hands, and you still contracted COVID19.

Realistically everyone’s next questions would be based on scientific data:

  1. What did you wash your hands with?
  2. How long did you wash your hands?
  3. How often did you wash your hands?

We need to think the same way and apply theory and scientific data to Cannabis:

  1. What cannabis product did you consume?
  2. How frequently did you consume Cannabis?
  3. What form factor of Cannabis do you consume? (inhaled, edibles, tinctures, etc.)

Cannabis plants are not all created equally. The plant contains more than 110 possible cannabinoids and over 120 terpenes, all of which work differently in the human body. To add yet another layer of complexity, research has found certain cannabinoids work differently with other cannabinoids/terpenes. This variable is called the entourage effect.

According to Strain Genie :

In addition to how Cannabis interacts with our human endocannabinoid system, there are other scientific data points to consider, our individual DNA. Research Scientist Nicco Reggente Ph.D., co-founder of Strain Genie, takes cannabis science to a whole new level by providing insight and data required to understand how we can use human DNA to further analyze how an individual metabolizes Cannabis, including the infamous intoxicating compound THC.

Strain Genie analyzes over 450 genetic biomarkers to recommend the best consumption methods and ratios per consumer. With this type of data and information, we can be less fearful of Cannabis as a potential aid in COVID19, knowing we will not have to walk around high or heavily sedated to prevent contraction and spread. It may even help you wash your hands a little longer!

Strain Genie uses DNA biomarkers to align cannabinoids and terpenes within the cannabis plant the help tame or mitigate much of the “high” with Cannabis by providing a custom THC: CBD ratio along with additional terpenes to pair when looking to combat things like cannabis-induced anxiety in individuals that may also be genetically predisposed to having depression, PTSD, or OCD.

Let’s Put Actual COVID19 Under A Microscope With Cannabis:

Next, let’s apply this potential:

As you can see, the public-facing laboratory test for each harvest in our legal markets holds valuable data.  This is the type of data we can use to help propel us forward when thinking about Cannabis and the potential with COVID19. Cannabis consumers may request their products laboratory test upon purchase.

Could this lead to one of the most extensive human case studies in cannabis history?

Slight curveball, not every state-level legal growing operation, is required to provide a terpene content and potency profile. Currently, California, Michigan, Connecticut, and our nation’s capital District of Columbia are the only places that require a terpene profile on top of the cannabinoid profile per harvest; this makes them prime candidates to further research!

In closing, I believe we are much closer than ever to have the ability to quickly link cannabis COVID19 when looking for ways to prevent the spread, and potential treatments. We may find Cannabis as a temporary relief until a vaccine is created. This would allow us to open up more safely and to mitigate much of the risk. The world’s scientists, cultivators, and our states rigorous regulations and testing requirements that have progressed us forward while leaving a valuable data trail in a moment when time is not the most kind.

Caveats – AS ALWAYS PLEASE CONSULT WITH YOUR PRIMARY CARE PHYSICIAN BEFORE PURCHASING OR CONSUMING CANNABIS BASED PRODUCTS

  • Smoking cannabis is unfavorable, regardless.
  • Consuming cannabis may pose a risk to pregnant women.
  • Products with THC are not recommended for consumers with some cancer types where tumors are present.
  • Be aware Cannabis is known to have interactions with other medications.

About Lorelei Caudill – Cannabis Science 101 – www.cannabisque.org

I am a mother, a sister, a daughter, and a granddaughter. My family and I have personal experience with the medicinal value of Cannabis.

Over the past few years, I have dedicated much of my spare time to understand the science behind the “how” and “why” Cannabis works with the human body. Why do some consumers benefit from the medicinal value of Cannabis while others do not? Why would one product have little to no results, while others not only relieve symptoms but help with the root condition?

My goal with Cannabisque is to provide an unbiased platform of educational content created directly from highly regulated studies to educate Cannabis curious consumers globally as we learn more about this miracle plant the promise scientists are documenting in research today.

The Higher Ground Legal Stash Box! CoronaVirus Edition

A Highly Curated Cannabis Collection

The Coronavirus is a global pandemic, and to be taken seriously. And while we’re following scientific advice and protocols, we’re also aware of the need to medicate – which is where the Higher Ground Legal Stash Box: CoronaVirus Edition comes in. Curated from legal markets across the country, we’ve hand-selected the items to help you continue using cannabis for a health buzz – as well as sanitizers, hemp masks and CBD to calm our nerves in this very strange time.
Some common-sense info for the canna-community during the CoronaVirus outbreak include the following: Don’t share joints, vapes, pipes or bongs. If you do share a smoking device, have a disinfectant wipe handy to swap the piece before sharing. Obviously, if you’re feeling sick – skip any smoking or recreational cannabis session. COVID-19 causes infections in the nose, throat and lungs. Since – over time – smoking cannabis can impact lung health, it’s best to take a break from smoking or vaping until you’re feeling better or have been tested. Finally, maintain social distancing, even among friends at smoke sessions. One person on a recliner, another pacing the room, and a third on the couch will do the trick. Just be smart, follow guidelines, and common sense.
The notable selections in this Higher Ground Legal Stash Box, CoronaVirus Edition include:
The CDC recommends wearing cloth face coverings in public settings where other social distancing measures are difficult to maintain (e.g., grocery stores and pharmacies). Luckily, we can support businesses using hemp and promote cannabis through the masks we purchase and wear. An example of reusable, breathable and washable hemp face masks with a natural hemp filter is a great option. The hemp fibre filter is encased in cotton for comfort and make the face mask easy to wash for reuse.
While we have one of these insane contraptions below in the Higher Ground office, it is NOT recommended to replace an actual mask, and should be used with caution. (Wearing a mask when you go out not only protects the user, but others who may become infected.)
The use of edibles can eliminate exposure to potential lung irritants entirely, and Kin Slips is an innovative and slick option. Kin Slips was founded by a passionate group of entrepreneurs hell-bent on reimagining cannabis and developing the most efficient products around. Their commitment to providing an alternative cannabis consumption experience began with these sublingual strips —a infused product that is discreet and all-natural, and provides health and wellness conscious consumers with a consistent, smoke-free cannabis experience. Kin Slips dissolve under the tongue to deliver a precise dose of CBD or THC. Unlike traditional edibles, Kin Slips absorb directly into the bloodstream to bypass the digestive system, enabling an onset of about 15 minutes and are available in standard dose (10MG) and micro-dose (5MG) formulas, which allow consumers easy control over their preferred experience that’s tailored by the variations they offer; Creativity and Focus, Comfort and Relief and Sleep and Serenity. In our box are “Park Life” strips, minty fresh with hints of tumeric, each has a 10:1 ratio of CBD to THC that works nicely to help take the edge off – like a stroll in the park.
Many folks are stressed to the max, and having difficulty sleeping; it’s no wonder – we have a reality-show buffoon running the sitch. There are many sleep-aid options in the cannabis world, including CBD-rich gummies, transdermal patches, and capsules with CBD and melatonin. One of our favorite ways to end the evening is via the Beboe Downtime Vaporizer. Beboe is a luxury cannabis brand, and their gorgeous rose gold pen comes in a glass test tube (we admit it – we are obsessed with cool packaging), with a letterpresses label in gold foil. The Beboe Indica Downtime vape pen is intended for quiet evenings at home, great for reducing anxiety and winding down. A relaxing combination of the choicest Indica-dominant strains makes the Downtime Pen an excellent way to smooth out life’s stresses at the end of a long day, and is a go-to cure for stress and insomnia without any of the usual next-day grogginess.
The Nuggy is the Swiss Army Knife for potheads – and Lord KNOWS what challenges lie ahead in this Corona-ClusterF*ck. While others stock up on AK-47s, chainsaws and ATVs, we prefer tools we can use – like the “Original Smoker’s Multi-Tool!” The Nuggy is a 10-in-One, pocket friendly multi-tool designed specifically for smokers. This stoner-survival tool has everything a real connoisseur could possibly need to help with rolling, cutting, shredding, dabbing, scraping, poking and vaping all packed into one durable unit. The designers have managed to fit 10 must have spring-locking tools into this super compact pocket size device including: a knife, scissors, roach clip, tamper, mini spoon, herb bowl scraper, bottle opener, flat head screwdriver, pointy pick AND an LED flashlight! Cuz, you know, it’s kind of dark out right now…
For those of us who just like the wonderful tradition of smoking a joint, we’re including Mini Joints in the CoronaVirus Stash Box. With small doobies (aka DogWalkers), joints are small enough for a single person using it without the threat of passing on a virus through saliva exchange. Also, kind of hard to be socially distant while passing the blunt.
Island Minis: With five 0.5 gram pre-rolls in each box, Island all-flower Minis are the perfect combination of fun and flavor. Island is a for-benefit organization, and their commitment extends beyond providing cannabis that is both safe and effective. Island actively supports organizations focused on positive social change and have made it part of their mission to give back to our community.
TRIPLE J’S ORIGINAL MINI JOINTS come in different blends to suit every lifestyle; Hybrid, Indica, Sativa and Enhanced with Kief. Known for quality, convenience, and reliability, Triple J’s are assembled by hand in a process that ensures the best quality experience every time without the hassle of rolling your own.
Tinctures are a great way to consume cannabis, and there are a million combinations of THC, CBD and plant materials to fine-tune a particular experience or relief. Sativa Valley Blueberry CBD tincture is formulated to help reduce anxiety, inflammation, and aid in insomnia relief. Paired with a variety of fruit extract flavors, their organic sublingual tincture is placed under the tongue to produce different effects depending on the serving size: calming and anxiety relief effects at low milligram servings sizes, while anti-inflammatory and muscle pain relief is achieved with medium to higher milligram serving sizes. Best of all, Sativa Valley participates in “Wildcrafting” – an age-old practice of collecting plant materials in their natural habitat for food, medicine, and craft.
We know that COVID-19 attacks the respiratory system and is more dangerous for people with additional health issues. While clearly not mandated, people may consider limiting or refraining from smoking as a cautious prevention method. Vaporizers, multi-chamber water pipes, and edibles are simple going to be better on the lungs. The DaVinci MIQRO and IQ Vaporizers, for example, are ultra-portable vapes designed for the solo vape connoisseur, convection-cooking your cannabis to the perfect temp – and not causing lung irritation.
As insomnia affects around 30% of Americans and can pose greater risk factors for those suffering from chronic pain, cardiovascular disease, and mental disorders, many are finding relief through cannabis to sleep through the night. We like the wok of Lord Jones, who manufactures some of the world’s finest hemp-derived CBD infused topicals and ingestibles. Lord Jones gumdrops and chews are made by hand in small batches with the finest ingredients and CBD extract derived from select hemp cultivated in the USA. Their hemp-derived CBD oil retains the plant’s original terpenes and phytocannabinoids for broad and full spectrum formulations, and are lab-tested to ensure proper purity and potency. One of our favorite canna-collaborations are their work with the great band Sigur Ros. Together they created cannabidiol-infused (CBD-infused) gumdrops called “Wild Sigurberry!” The limited-edition collection of medicated gumdrops are a “proprietary terpene blend designed to provide a calming sense of well-being inspired by the music of Sigur Rós, “Wild Sigurberry” was inspired by the flavors of foraged berries from the band’s home country – and we’re inspired by the teamwork.
Wash your hands early & often! We all know the drill – and we’re personally using the first verse from Bob Marley’s “Three Little Birds” as our washing duration song!
When soap and water are not readily available, the use an alcohol-based hand sanitizer is equally effective. Hand Sanitizers by Dr. Bronners Soap are essential tools to help keep Covid-19 from spreading and help maintain public health. And Dr. Bronners has always been the coolest all-organic company around, leading the charge to be eco-friendly, and donating to wonderful pro-cannabis organizations. Most recently, Dr. Bronners is working on campaigns for more widespread therapeutic use of psilocybin, the psychedelic compound in magic mushrooms, donating a million dollars to a legalize psilocybin therapy initiative in Oregon.Family-owned and run since 1948, Dr. Bronners are allotting a reserve of 2% of all hand sanitizer production to donate to at-risk communities and the organizations that serve them, so they have access to the hand sanitizer as well, and are continuing to work with advocates and service providers to get their products in the hands of those who need them most during this public health crisis.

“Life is just a bowl of cherries.”

Originating as the title of a song (1931) by Lew Brown (lyrics) and composer Ray Henderson, this term expressed the idea that everything was going very well – and life was wonderful. (Today it’s often used ironically, but we’re looking on the bright side.) Clearly, things are quite odd in our CoronaVirus realm. But we’ll make it through, and hope to accentuate the positive – and something that’s pretty darn great are Goodship Tart CHERRY Pastilles. Tart and fruity, Goodship confections are made from all-natural, locally-sourced and sustainable ingredients. Each “sweet tart” pastille is micro dosed at 2.5mg per piece, giving a consistent, uplifting and delicious experience each go-round. Best of all, Goodship tarts come in a beautiful embossed tin – which you can put joints and buds in when the pastilles are long gone.
While the Higher Ground Legal Stash Box is not available for purchase, there are several high end curated delivery boxes for sale, including Club M  and PotBox
Stay tuned to MJ News Network where we will continue to curate the best in legal cannabis, and highlight the most innovative and elegant brands in upcoming Higher Ground Legal Stash Boxes.
Higher Ground is the World’s first talk show highlighting cannabis culture. Think of it as “The Daily Show” meets “Good Morning America”…but with a giant bong on the desk. For more on Higher Ground and host Michael Stusser, visit www.highergroundtv.com or www.michaelstusser.com

Medical Marijuana, Inc Subsidiary HempMeds Brasil Sponsors Autism Event At Rice University In Houston

 CALIFORNIA: Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronger” at Rice University on February 22.

“We see events like this one as prime opportunities to educate people on what cannabidiol, or CBD, is and its potential benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “CBD can be legally imported in Brazil and is even subsidized by the Brazilian government for many indications including autism. We want to do everything we can to help bring awareness to current research that is being conducted on how CBD can be used by people around the world.”

In addition to sponsoring the event, HempMeds® Brasil shared the event stage with two researchers who the Company has worked with frequently in the past, Dr. Alysson Muotri, Professor at the School of Medicine, University of California in San Diego, and Dr. Abram Topczewski, Neuropediatrician and Enuresis Clinic Director at the Albert Einstein Hospital.

“Education is the most important thing when it comes to helping the world become more accepting of cannabis and its compounds,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re proud to be able to sponsor events like these and work with such prestigious doctors such as Dr. Muotri and Dr. Topczewski to help further medical research around the world.”

USDA Announces Details Of Risk Management Programs For Hemp Producers

DISTRICT OF COLUMBIA: The U.S. Department of Agriculture (USDA) has announced the availability of two programs that protect hemp producers’ crops from natural disasters. A pilot hemp insurance program through Multi-Peril Crop Insurance (MPCI) provides coverage against loss of yield because of insurable causes of loss for hemp grown for fiber, grain or Cannabidiol (CBD) oil and the Noninsured Crop Disaster Assistance Program (NAP) coverage protects against losses associated with lower yields, destroyed crops or prevented planting where no permanent federal crop insurance program is available. Producers may apply now, and the deadline to sign up for both programs is March 16, 2020.

“We are pleased to offer these coverages to hemp producers. Hemp offers new economic opportunities for our farmers, and they are anxious for a way to protect their product in the event of a natural disaster,” said Farm Production and Conservation Undersecretary Bill Northey.

Why Athletes Should Consider Taking CBD

It’s no secret that the life of an athlete can be rough. Hour after hour of cardio, lifting weights and refining your skill set is bound to be accompanied by soreness and other ailments that, if ignored, could lead to greater risk of injury. Of course, if you’re serious about your athletic goals, you’ve likely steeled yourself to the inevitability of injuries. “Pain is just weakness leaving the body” is a phrase that you’ve almost definitely heard at least once in your life, and while the sentiment is positive, it supports a flawed mindset.

As it stands, there are several ways in which you can address pre and post workout ailments, some being more natural than others. You could always try stretching properly and allowing your body adequate time to recover from the work it put in, but this is easier said than done. You won’t always get the chance to stretch/rest, and even if you do, you’ll really only be able to mitigate a small portion of the soreness and pain that you feel. Certain products and medications are being hailed for their anti-inflammatory effects, but the negatives that come with them far outweigh the relief that they may or may not bring.

As professional athletes are discovering, there are more natural means of achieving relief that avoid the dangers of addictive prescriptions and other potentially harmful products. CBD is a potential answer to many of the aches and pains that you suffer from in your athletic ventures. In multiple studies, the compound has been found to possess anti-inflammatory properties, preventing you from encountering much of the soreness that you would usually encounter.

CBD, or cannabidiol, enters your body and is absorbed into your bloodstream, where it seeks out the receptors that make up your endocannabinoid system. This system runs throughout your body and is a key component in ensuring that your body remains in homeostasis — a state that is disrupted by pain and inflammation, among other things. It produces its own form of cannabinoid, which is sent and received by different receptors within the system. When CBD is introduced to this system, it can act as an endocannabinoid, both boosting the system’s activity and preventing the release of certain neurotransmitters that would result in feelings of pain and discomfort.

It only makes sense, then, that CBD would be embraced by the world of athletics with open arms. Athletes could benefit from adding CBD products to their daily workouts, and they could even use these products as part of their pre and postgame routines as well. It would provide them with a means of recovering from especially intense workouts and games, potentially preventing them from waking up and having to will their bodies out of bed the following morning.

CBD products such as CBD balms and hemp creams are the perfect gym buddies, fitting into any bag and offering availability at a moment’s notice. Unlike the creams and balms that can normally be found in gym bags, these also boast servings of high-quality CBD hemp extract, and if you’re buying from reputable sources, such as the lab-tested products by CBDfx, you’re sure to get a product that walks the walk.

While the number of active athletes backing CBD might seem small, it’s mainly because of the rules currently prohibiting the compound. For years, CBD has been lumped in with other compounds found in cannabis plants that possess psychoactive effects, and therefore it’s been kept away from professional athletes. However, now that it’s widely understood that CBD doesn’t possess any psychoactive or intoxicating effects, sports leagues are warming up to the compound.

Meanwhile, multiple prominent ex-professional athletes are championing the cause for CBD in athletics, including those with backgrounds in everything from baseball to bicycling. MLB and NBA hall of famers such as Goose Gossage and Rick Barry are actively campaigning for the acceptance of CBD as an alternative to the more controversial medications that athletes are currently being subjected to.

Many ex-pro sports advocates are also pointing to CBD’s anxiolytic (anti-anxiety) effects as a reason for the compound to be permitted for athletes. Social anxiety is just as prevalent amongst athletic superstars as it is for the rest of the world, and ex-NBA champion Paul Pierce is even on record stating that he used CBD for the express purpose of curbing his feelings of anxiety and depression.

With a million reasons to embrace CBD and little to no reason not to, it seems obvious that the compound should — and will — thrive once made more available to athletes and the world of sports in general. Its anxiolytic and anti-inflammatory attributes are only the tip of the iceberg, and its other facets will prove just as crucial to your own athletic aspirations. It’s only a matter of time before the floodgates open and CBD gains the limelight that it so rightfully deserves.

Sources:

  1. Vučković, Sonja, et al. “Cannabinoids and Pain: New Insights From Old Molecules.” Frontiers, Frontiers, 15 Oct. 2018, www.frontiersin.org/articles/10.3389/fphar.2018.01259/full.
  2. Small, Jonathan. “Why Paul Pierce Jumped On The CBD Train.” GreenEntrepreneur, 15 Nov. 2019, www.greenentrepreneur.com/article/340942.
  3. Iffland K, Grotenhermen F (2017) An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies, Cannabis and Cannabinoid Research 2:1, 139–154, DOI: 10.1089/can.2016.0034.

How To Begin Investing In Marijuana

With the legalization of marijuana in specific areas of Canada and the United States, you may be interested in investing in this high-growth industry. To understand the best way to do this, you need to know about the different types of marijuana stocks and what you should look for when you’re investing.

Understanding the Different Types of Marijuana Products

Over 30 US states have legalized marijuana for medical use, and in some states, it can be sold recreationally. If a person wants to purchase medical marijuana, they’ll need a prescription from a healthcare provider, which is usually for symptoms such as depression, anxiety and stress.

Medical marijuana is available in different forms that can be smoked, vaped or consumed via beverages or edible products. Cannabidiol (CBD) is a common product that comes from the cannabis plant. It doesn’t contain delta-9 tetrahydrocannabinol (THC), which has psychoactive properties. These products are usually used for health benefits.

Marijuana products that contain THC are typically used by recreational users who want to feel the effects of psychoactive properties. They tend to smoke cannabis flowers, vape concentrates or consume edibles.

Different Types of Marijuana Stocks

When you’re looking for the best marijuana stock to invest in, it’s important to understand the different types available, which include the following:

Cannabis Retailers and Growers: Companies involved in this category are involved in cultivating cannabis, which is usually done in greenhouses or large indoor facilities. They will harvest their crops and distribute end products in the form of concentrates, flowers or edibles. These companies or other independent companies can also choose to operate retail stores, which sell recreational and/or medical cannabis.

Ancillary Services and Products: It takes specific equipment to grow marijuana. The companies in this category supply lighting and hydroponic systems to marijuana growers. Large fertilizer companies can also be included in this niche.

Biotechs Focusing on Cannabis: Some biotech companies focus primarily on creating cannabinoid drugs.

Basics of Cannabis Investing for Beginners

When you invest in marijuana stocks, it’s important to apply the same type of basics that you would for any stock investment. You may want to check out the management team of a company and examine their track record. It’s best to find companies that have a strategy put in place for growth, which might include an organic plan or expansion via acquisitions.

You’ll also want to analyze competition when you’re looking for the best marijuana stock to invest in. Try and find a company that differentiates itself. You can do this by seeing if a company is working with top partners or producing a profit. The marijuana industry is still in its infancy, which means you will probably find companies that aren’t generating profits. This can be a good plan if they are focusing on growing their operations.

It’s also helpful to learn if a company is focused on targeting specific geographic markets. Each geographic market will present a unique opportunity, which can be highly beneficial to a company if they are the leader in that area.

Benefits of Investing in Marijuana

When you’re investing in the stock market, you can choose to purchase stocks and industries that are riskier than others. Marijuana stocks provide this opportunity. They can be more volatile than a lower risk energy stock or stocks related to companies selling consumer products such as household detergents. The benefit of investing in marijuana stocks becomes apparent when you look at the rewards and profits they can create.

Like any investment, you need to look at your risk profile and decide how much you want to invest in your first position. If your risk profile allows you to invest 30 percent in the category of higher-risk stocks, you may want to include one or more marijuana stocks in that part of your portfolio. To do this, it’s usually best to begin with a small position. If you recognize an uptrend in the stock or stocks you’ve invested in, you can always add more shares in the future.

Now that you have learned more about the basics of the marijuana industry and how to find different marijuana stocks, it’s time to do some research and decide on the type of company you’d like to invest in. This will help you pinpoint your decision when you are ready to make a purchase.